society
abstractinstruct
business
conferences
forms
information
membership
newsletters
protect
resources
transactions
index

Abstract Instructions and Submission

AMERICAN OTOLOGICAL SOCIETY, INC.
The One Hundred Forty-Fourth Annual Meeting
Sheraton Chicago Hotel & Towers
Chicago, IL
April 30 - May 1, 2011
Deadline for abstract submission: October 15, 2010

Abstract Submission Instructions: Please read all instructions carefully before you begin your submission. Click here to download a pdf file of the following instructions. Failure to comply with the instructions will disqualify your abstract submission. Please contact the AOS Administrative Office if you have any questions prior to submitting your abstract.
Email - segossard@aol.com
Ph: 352-751-0932
Cell: 217-414-4868

The American Otological Society accepts on-line submission of abstracts to www.americanotologicalsociety.org.

The electronic version is not to contain any extraneous formatting instructions.

Acknowledgment of receipt of an electronic submission will be sent electronically from the AOS Administrator to the primary author.

Abstracts must be structured according to Otology & Neurotology Guidelines for Authors

General Format:
A concise abstract of not more than 250 words or less is required for all original clinical and basic science contributions, including review articles. The AOS Program Advisory Committee reviews all abstracts. Please do not place any identifying information in the body of the abstract, such as referral to authorship or institution. Also, if the research in your paper is supported by a grant, or special financial arrangement, this must be identified. These should be organized according to the headings outlined below. The author(s) must accept sole responsibility for statements in their submitted abstract.

Choose an appropriate title reflecting the content of the abstract body. The title will appear in all publications if chosen for presentation. Do not capitalize prepositions, a, an, the, etc. No changes to abstract will be accepted after October 15. Do not include the author’s name(s) in the abstract title or body of the abstract.

List all authors in proper sequence (limited to 6 individuals) using first names, middle initials, and last names and exact designations (i.e. MD, PhD, MS, etc.) Specify the primary author and the presenter of the abstract. If a presenter is not specified, we will assume the presenter will be the primary author. Please specify a corresponding author if different than the Primary author to whom all correspondence about the abstract will be directed.

The AOS Program Advisory Committee will require a completed manuscript to the Otology & Neurotology Journal three weeks before the scientific meeting. The AOS Program Advisory Committee and members of the AOS/ANS Joint Council will review the manuscript for any commercial bias, conflict of interest, use of commercial names and any other identifying information that may conflict with the ACCME requirements. The AOS Program Advisory Committee may ask you to revise submitted abstract to enforce compliance with the ACCME requirements. Failure to comply will disqualify your presentation from the AOS program.

For clinical studies:
Objective: Brief, clear statement of the main goals of the investigation.
Study design: Specify the type of study-randomized, prospective double blind; retrospective case review; etc.
Setting: Primary care vs. Tertiary referral center; ambulatory vs. hospital; etc.
Patients: Primary eligibility criteria and key demographic features.
Intervention(s): Diagnostic, therapeutic, and/or rehabilitative.
Main outcome measure(s): The most essential criterion that addresses the study’s central hypothesis.
Results: Include statistical measures where appropriate.
Conclusions: Include only those directly supported by data generated from this study.

For basic science reports:
Hypothesis: Brief, clear statement of the main goals of the investigation.
Background: Concise orientation for the reader unfamiliar with this line of investigation.
Methods: Succinct summary of techniques and materials employed.
Results: Include statistical measures where appropriate.
Conclusions: Include only those directly supported by data generated from this study. Emphasize clinical relevance wherever possible.

For reviews and meta-analysis:
Objective: Brief, clear statement of the goals of the review.
Data sources: Specify database, search methodology, languages covered, and time frame.
Study selection: Criteria used to select articles for detailed review.
Data extraction: Means of assessing quality, validity, and comparability of extracted data.
Data synthesis: Specify statistical techniques used for data analysis.
Conclusions: Concise statement of primary inferences with any recommendations.

For All Human Studies: Indicate IRB Approval Number

Was outside funding provided for this research/project, if so, you will be asked to name the source.

The AOS Program Advisory Committee will not consider abstracts that do not contain the required elements.

In order to begin the Abstract submission process, the Primary author must complete the Conflict of Interest/Disclosure & Attestation form electronically through the AOS website. Upon successful completion of the COI Disclosure, you will be directly linked to the Abstract Submission page. As the primary author, it is your responsibility to see that each author complies with the COI Disclosure guidelines. To review the content of the Conflict of Interest/Disclosure & Attestation form prior to your mandatory electronic submission, please click here for a hard copy of the document to notify the co-authors of their accountability to disclose.

To simplify the process, after all the author’s have reviewed the Disclosure/Attestation, the primary author will collect disclosure information from every author named on the abstract (limited to 6 individuals); list his or her Full name and Designation, record their specific disclosure, if any, by marking the appropriate checkbox for each individual.
ONLY AUTHORS NAMED ON THE ELECTRONIC DISCLOSURE WILL BE PUBLISHED IN ANY PROGRAM MATERIAL.

Conflict of Interest/Disclosure & Attestation form MUST be submitted electronically. We will NOT except faxed forms.

The Abstract submission process cannot be started until the Conflict of Interest/Disclosure & Attestation form has been completed

Click here to complete the mandatory Conflict of Interest/Disclosure & Attestation form. or https://www.surveymonkey.com/s/aosdisclosurespring2011

Author Responsibility/Financial Disclosure/Conflict of Interest & Attestation Form:

The American Otological Society and the AOS/ANS Joint Council, as the ACCME Accredited CME provider, is dedicated to ensuring that all content reflects the latest scientific evidence and provides a balanced discussion of topics, advances, and controversies in this specialty. The AOS and the AOS/ANS Joint Council requires all authors to comply with the standards set forth by ACCME regarding commercial bias and/or support. Therefore, all authors (primary and contributing) are responsible for disclosing any potential conflict of interest prior to consideration of presentation.

Conflict of interest of an individual has two components:

1) A financial relationship with a commercial interest (e.g., pharmaceutical company or medical device manufacturer)

2) The opportunity to influence content of a CME activity relevant to products and services of that commercial interest.
    • Presentations cannot be focused on new product development or services but are focused on patient-centric approaches to care.
    • The author(s) agree to disclose all non-FDA approved use of FDA approved drugs or medical devices at the time of abstract submission and prior to the actual oral presentation should your abstract be selected for presentation.

In order to comply with the ACCME requirements, the primary author and contributing authors are required to disclose any conflict of interest or potential commercial bias at the time of abstract submission. The primary author accepts responsibility to electronically submit the conflict of interest/disclosure declarations from each co-author.

The Abstract Submission page will include the following, please be prepared to answer each question/item. It is imperative that both the Abstract title and Primary author name is an identical match on both the Disclosure form and the Abstract Submission page.


TITLE OF ABSTRACT:
Capitalize each primary word in the title, (do not capitalize prepositions such as a, an, the, etc.,) use same format for the body of the abstract. Do not include the author’s name(s). (No changes accepted after 10/15/10)

AUTHORS:
List all authors in proper sequence (numbering 1, 2, 3, etc., if applicable) using FIRST NAMES, MIDDLE INITIALS, AND LAST NAMES AND EXACT DESIGNATIONS. (No changes accepted after 10/15/10)

NAME, ADDRESS, TELEPHONE, FAX NUMBER, E-MAIL OF PRIMARY AUTHOR:

NAME, ADDRESS, TELEPHONE, FAX NUMBER, E-MAIL OF PRESENTER AT COSM:

IDENTIFICATION OF PROFESSIONAL PRACTICE GAPS, LEARNING OBJECTIVES, & DESIRED RESULTS

Professional practice gaps are the variations or differences in the practice patterns when compared to current evidence, standards of care or clinical guidelines that are designed to provide quality of care to patients. Describe how you translate identified professional practice gaps into educational needs; how the need is expressed in terms of knowledge, competence, performance and patient outcome; what should the learners be able to apply to their profession after they participate in the educational activity; list the desire results in terms of changes in physician knowledge, competence, performance and/or patient outcome.

Please identify the professional practice gaps, educational needs, learning objectives, and desired results

Define Professional Practice Gap & Educational Needs:
Learning Objective:
Desired Result:

The following competency areas will be addressed - Please select (any/all) competency areas your presentation will address

• Patient Care that is compassionate, appropriate, and effective for the treatment of health problems and the promotion of health
• Medical Knowledge about established and evolving biomedical, clinical, and cognate (e.g. epidemiological and social-behavioral) sciences and the application of this knowledge to patient care
• Practice-Based Learning and Improvement that involves investigation and evaluation of their own patient care, appraisal and assimilation of scientific evidence, and improvements in patient care
• Interpersonal and Communication Skills that result in effective information exchange and teaming with patients, their families, and other health professionals
• Professionalism as manifested through a commitment to carrying out professional responsibilities, adherence to ethical principles, and sensitivity to a diverse patient population
• Systems-Based Practice as manifested by actions that demonstrate an awareness of and responsiveness to the larger context and system of health care and the ability to effectively call on system resources to provide care that is of optimal value.

Abstract (250 words or less)

IRB or IACUC Approval (if applicable)

Was outside funding provided for this research/project? If so, please name.

Copyright Transmittal:
Abstracts are received with the understanding that they are not under simultaneous consideration by another publication and that they are original contributions that have not been previously published. Accepted abstracts become the permanent property of the Otology & Neurotology Journal and may not be published elsewhere without permission from Otology & Neurotology

Publication Statement:
The material in this abstract, has not been submitted for publication, published, or presented previously at another national or international meeting and is not under consideration for presentation at another national or international meeting including another COSM society. The penalty for duplicate presentation/publication is prohibition of the author from presenting at a COSM society meeting for a period of three years.

*State Yes or No if this abstract has been considered for or denied publication and/or presented at any other Scientific meeting

Please review all instructions carefully. Failure to comply with the instructions could delay the review of or disqualify your abstract submission. Abstracts submitted for publication, published, presented previously or considered for presentation at another national or international meeting may not be submitted. Duplicate submission to more than one COSM society will disqualify your paper.


Submitting author’s Electronic signature OR Fill in name:

*
Signature indicates author will abide by the above Copyright and Publication statements:

American Otological Society
Administrative Office
Shirley Gossard, AOS Administrator
3096 Riverdale Rd
The Villages, FL 32162
Fax: 352-751-0696
Ph: 352-751-0932
Cell: 217-414-4868
Email: segossard@aol.com





Web AOS
© The American Otological Society